EMA publishes Video explaining the new Pharmacovigilance Legislation
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The European Medicines Agency has produced a video with an introduction to the new pharmacovigilance legislation. Watch Dr Peter Arlett, Head of Pharmacovigilance and Risk Management, talking about the new and improved tools for regulators in Europe to ensure that patients are not exposed to unnecessary risks when taking medicines.
The new pharmacovigilance legislation came into operation on 2 July 2012. Its aim is to promote and protect public health by strengthening the existing Europe-wide system for monitoring the safety and benefit-risk balance of medicines.
Source and video
Related GMP News
18.03.2026ICH M4Q(R2): List of comments published
11.03.2026ASMF: CMDh updates Information on "Worksharing Procedure"
04.03.2026CMDh: Update of Q&As for Generic Drug Submissions
18.02.2026HMA/CMDh: Update to the Best Practice Guides on Variations
11.02.2026Q&As for Centralized Procedures - further Update
04.02.2026EMA: IRIS Document revised